Labquality Corporation acquires Kasve Oy. Kasve is a Finnish company specializing in digital and software services and regulatory services. Their target groups are the health technology industry, in vitro diagnostic manufacturers, and laboratories. Kasve is a market leader in digital and software services for medical device manufacturers in Finland. Kasve and its experienced professionals further strengthen Labquality’s digital health technology and regulatory affairs competencies. The acquisition is in line with Labquality’s international growth strategy.
The acquisition enables Labquality to gain ground at the forefront of the digitalization of health technologies. “Kasve fits perfectly into our Labquality family, complementing our regulatory consulting business. Moreover, Kasve enables us to become a strong player in the digital health market. Now, we can offer new digital and software solutions for our customers, and our growing team of regulatory consultants can utilize Kasve’s digital toolbox in their projects. Kasve’s experience and competence in software and digital services will further strengthen our market position,” says CEO Juha-Pekka Nuutinen from Labquality.
“Labquality has an established and highly valued regulatory affairs expertise and a clear strategy to take digitalization to the next level. Becoming part of Labquality enables us to offer our digital and software solutions to the international health technology market. Together, we can make a difference with digital health solutions and build a more sustainable future,” concludes Mikko Juuti, the founder and CEO of Kasve.
The acquisition strengthens Labquality’s position as an expert services provider for the health technology industry.
The acquisition does not impact the current customer relationships, partnerships, or personnel of Kasve or Labquality.
For queries, please contact:
Juha-Pekka Nuutinen
CEO | Labquality
+358 40 828 3210 | jp.nuutinen@labquality.com
Mikko Juuti
CEO | Kasve
+358 40 485 8826 | mikko.juuti@kasve.com